Pregabalin formulations and use thereof
AssigneeOrion Corporation
InventorsMirja HUHTINEN, Terttu LAMMINEN, Jukka SALMIA, Johanna TERVAPURO, Jurgen VERCRUYSSE
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical composition in the form of an orally deliverable liquid composition comprising pregabalin as an active ingredient and to the use thereof in the treatment and prevention of transportation and veterinary visit anxiety and fear in companion animals, such as cats. The composition is stable, well palatable to animals and can be easily administered by the pet owner.
Claims21
A liquid pharmaceutical composition adapted for oral administration comprising:
- (i) pregabalin as an active ingredient at a concentration of at least 35 mg/ml;
- (ii) a flavouring agent;
- (iii) a preservative;
- and
- (iv) water;
- wherein the pH of the composition is from about 3.0 to about 4.4.
A method for the treatment or prevention of transportation and veterinary visit anxiety and fear in a companion animal comprising administering to the companion animal in need thereof an effective amount of a composition comprising pregabalin as an active ingredient.
14-17. (canceled)
A medicinal kit comprising a) a liquid pharmaceutical composition adapted for oral administration comprising pregabalin as an active ingredient, b) a package for containing said composition, and c) instructions for administering said composition to a companion animal, particularly cat, for the treatment or prevention of transportation and veterinary visit anxiety and fear.
Dependencies are inferred from the claim text.